JL Armstrong DK Huang HQ . Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study . Gynecol Oncol
Search Results
Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?
Pankaj Singhal and Shashikant Lele
Counterpoint: Intraperitoneal Chemotherapy: An Investigational Treatment in Ovarian Cancer
Robert F. Ozols
compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer . Gynecologic Oncology 1993 ; 50 : 100 – 104 . 10 Walker JL Armstrong D Bundy BN . Intraperitoneal catheter outcomes on GOG 172: Randomized
Oncology Research Program
-paclitaxel (Abraxane) as a single agent administered intraperitoneally via an intraperitoneal catheter Secondary Objectives: Evaluate the pharmacokinetics of nab-paclitaxel (Abraxane) in the plasma and peritoneum when administered directly into the peritoneal
Oncology Research Program
Objectives: Determine the MTD of nab-paclitaxel (Abraxane) as a single agent administered intraperitoneally via an intraperitoneal catheter Secondary Objectives: Evaluate the pharmacokinetics of nab-paclitaxel in the plasma and peritoneum when
Oncology Research Program
: Determine the maximally tolerated dose of nab -paclitaxel (Abraxane) as a single agent administered intraperitoneally via an intraperitoneal catheter Secondary Objectives: Evaluate the pharmacokinetics of nab -paclitaxel (Abraxane) in the plasma
Ovarian Cancer, Version 2.2013
Robert J. Morgan Jr, Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O’Malley, Richard T. Penson, Matthew A. Powell, Steven W. Remmenga, Paul Sabbatini, Joseph T. Santoso, Julian C. Schink, Nelson Teng, Theresa L. Werner, Mary A. Dwyer, and Miranda Hughes
with standard intravenous carboplatin and paclitaxel . Gynecol Oncol 2006 ; 103 : 1 – 6 . 38. Walker JL Armstrong DK Huang HQ . Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in
Epithelial Ovarian Cancer
Robert J. Morgan Jr., Ronald D. Alvarez, Deborah K. Armstrong, Barry Boston, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David Gershenson, Heidi J. Gray, Perry W. Grigsby, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Steven W. Remmenga, Paul Sabbatini, Russell J. Schilder, Julian C. Schink, Nelson Teng, and Theresa L. Werner
. Anticancer Res 2009 ; 29 : 2803 – 2808 . 74. Walker JL Armstrong DK Huang HQ . Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Lee-may Chen, Mihaela Cristea, Maria DeRosa, Eric L. Eisenhauer, David M. Gershenson, Heidi J. Gray, Rachel Grisham, Ardeshir Hakam, Angela Jain, Amer Karam, Gottfried E. Konecny, Charles A. Leath III, Joyce Liu, Haider Mahdi, Lainie Martin, Daniela Matei, Michael McHale, Karen McLean, David S. Miller, David M. O’Malley, Sanja Percac-Lima, Elena Ratner, Steven W. Remmenga, Roberto Vargas, Theresa L. Werner, Emese Zsiros, Jennifer L. Burns, and Anita M. Engh
-019-0543-1 31383985 239. Walker JL , Armstrong DK , Huang HQ , . Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology
